Title of article :
Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma: Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Init
Author/Authors :
Glasmacher، نويسنده , , Axel، نويسنده ,
